Use of adjuvant trastuzumab with chemotherapy in women with small, node-negative, HER2-positive breast cancers.

被引：3
|
作者：
McArthur, H. L.
Mahoney, K.
Morris, P. G.
Patil, S.
Jacks, L. M.
Howard, J.
Norton, L.
Hudis, C.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] New York Presbyterian Weill Cornell, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.615
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
615
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer
    McArthur, Heather L.
    Mahoney, Kathleen M.
    Morris, Patrick G.
    Patil, Sujata
    Jacks, Lindsay M.
    Howard, Jane
    Norton, Larry
    Hudis, Clifford A.
    [J]. CANCER, 2011, 117 (24) : 5461 - 5468
  • [2] High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancers
    Akiyo Horio
    Takashi Fujita
    Hironori Hayashi
    Masaya Hattori
    Naoto Kondou
    Mai Yamada
    Eri Adachi
    Aya Ushio
    Naomi Gondou
    Aiko Sueta
    Yasushi Yatabe
    Hiroji Iwata
    [J]. International Journal of Clinical Oncology, 2012, 17 : 131 - 136
  • [3] High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancers
    Horio, Akiyo
    Fujita, Takashi
    Hayashi, Hironori
    Hattori, Masaya
    Kondou, Naoto
    Yamada, Mai
    Adachi, Eri
    Ushio, Aya
    Gondou, Naomi
    Sueta, Aiko
    Yatabe, Yasushi
    Iwata, Hiroji
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2012, 17 (02) : 131 - 136
  • [4] Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
    Tolaney, Sara M.
    Barry, William T.
    Dang, Chau T.
    Yardley, Denise A.
    Moy, Beverly
    Marcom, P. Kelly
    Albain, Kathy S.
    Rugo, Hope S.
    Ellis, Matthew
    Shapira, Iuliana
    Wolff, Antonio C.
    Carey, Lisa A.
    Overmoyer, Beth A.
    Partridge, Ann H.
    Guo, Hao
    Hudis, Clifford A.
    Krop, Ian E.
    Burstein, Harold J.
    Winer, Eric P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (02): : 134 - 141
  • [5] Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer
    Cochereau, D.
    Cottu, P.
    [J]. ONCOLOGIE, 2015, 17 (04) : 194 - 196
  • [6] Trastuzumab and Chemotherapy May Be Appropriate for Small, Node-Negative, HER2-Positive Breast Cancer
    Morris, Patrick G.
    McArthur, Heather L.
    [J]. ONCOLOGIST, 2012, 17 (10): : E33 - E33
  • [7] Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer
    Cadoo, Karen A.
    Morris, Patrick G.
    Cowell, Elizabeth P.
    Patil, Sujata
    Hudis, Clifford A.
    McArthur, Heather L.
    [J]. CLINICAL BREAST CANCER, 2016, 16 (06) : 487 - 493
  • [8] Trastuzumab and Chemotherapy May Be Appropriate for Small, Node-Negative, HER2-Positive Breast Cancer In Reply
    Connolly, Roisin M.
    Bardia, Aditya
    [J]. ONCOLOGIST, 2012, 17 (10): : E34 - E34
  • [9] The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer
    Mette S. van Ramshorst
    Margriet van der Heiden-van der Loo
    Gwen M. H. E. Dackus
    Sabine C. Linn
    Gabe S. Sonke
    [J]. Breast Cancer Research and Treatment, 2016, 158 : 361 - 371
  • [10] The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer
    van Ramshorst, Mette S.
    van der Heiden-van der Loo, Margriet
    Dackus, Gwen M. H. E.
    Linn, Sabine C.
    Sonke, Gabe S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (02) : 361 - 371
12345